LBGTQ+ individuals often face disparities in health care and outcomes. These disparities can exist for many reasons, such as social and economic factors, barriers to care, discrimination in health care, and the stress of their minority status. 

We see health disparities particularly in cancer care among the LGBTQ+ community. The National LGBT Cancer Network estimates that there are 1 million LGBTQ+ cancer survivors in the United States, but limited research has been done to explore cancer care and outcomes among LGBTQ+ people. There are limited nationally representative health surveys that collect data about sexual orientation and gender identity which makes it difficult to fully understand the prevalence of cancer and cancer outcomes in their communities.

In a JAMA Oncology article, researchers recognized that “high-quality quantitative data on health outcomes for LGBTQ+ people with breast cancer are lacking.” They explored the disparities in breast cancer care that LGBTQ+ people face by using data from the Oncoshare database, which “integrates the data of patients with breast cancer across the Stanford and Sutter health care systems with the California Cancer Registry…” 

“Results showed patients from sex and gender minority groups experienced delays in time from symptom onset to breast cancer diagnosis compared with the cisgender heterosexual cohort…Moreover, patients from sex and gender minority groups appeared more likely to decline an oncologist-recommended treatment modality…and more likely to experience breast cancer recurrence.”

This research can help us better understand the disparities LGBTQ+ individuals face in cancer care, but more research is needed. Including data on gender identities and sexual orientation in quantitative health surveys and cancer registries becomes important to understanding these health disparities. Providing adequate training for healthcare providers regarding LGBTQ+ health is also key to addressing disparities.